Literature DB >> 18571942

Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.

Lizzia Raffaghello1, Massimo Conte, Elisa De Grandis, Vito Pistoia.   

Abstract

Opsoclonus-myoclonus syndrome is a rare paraneoplastic disorder, often associated with malignancies including neuroblastoma (NB), the most common solid tumor of childhood derived from the sympathetic nervous system. The pathogenesis of this syndrome is still undefined but is suspected to be the result of an autoimmune response. In this respect, different autoantibodies binding to neurons or cerebellar Purkinje cells have been detected in OMS-associated NB. In addition, immunohistochemical analysis of NB affecting children with OMS demonstrated the presence of interstitial or perivascular lymphoid infiltrates resembling secondary lymphoid follicles. Immunophenotyping of these lymphoid cells showed the existence of a mesh of CD21(+) follicular dendritic cells, numerous CD20(+) B lymphocytes in the germinal center and the mantle zone of the follicle and few CD3(+) T lymphocytes in a perifollicular area. Since information is lacking about the mechanism involved in ectopic lymphoid neogenesis of OMS-associated NB, we are currently investigating the role of different chemokines and their cognate receptors in the recruitment of lymphoid cells within tumor mass of OMS-associated NB. Here, we review some recent data about the pathogenesis of OMS-associated with NB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571942     DOI: 10.1016/j.ejpn.2008.04.012

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  11 in total

1.  Paraneoplastic neurologic disorders in children.

Authors:  Elizabeth M Wells; Josep Dalmau
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 2.  Review of paraneoplastic syndromes in children.

Authors:  Grace My Ma; Jeanne S Chow; George A Taylor
Journal:  Pediatr Radiol       Date:  2019-03-16

3.  Opsoclonus-Myoclonus in a Patient With Japanese Encephalitis: A Video-Based Case.

Authors:  Kumar Saurabh; Reyaz Ahmad
Journal:  Cureus       Date:  2022-03-24

4.  Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases.

Authors:  Benedikt Maria Huber; Susi Strozzi; Maja Steinlin; Christoph Aebi; Simon Fluri
Journal:  Eur J Pediatr       Date:  2009-09-24       Impact factor: 3.183

5.  Paraneoplastic brain stem encephalitis.

Authors:  Franz Blaes
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

6.  Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study.

Authors:  Michael R Pranzatelli; Elizabeth D Tate; Nathan R McGee
Journal:  Front Neurol       Date:  2017-09-11       Impact factor: 4.003

Review 7.  The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours-Single-Centre Experience and Literature Review.

Authors:  Agnieszka Mizia-Malarz; Weronika Stolpa; Grażyna Sobol-Milejska
Journal:  Medicina (Kaunas)       Date:  2020-08-14       Impact factor: 2.430

Review 8.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

9.  Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.

Authors:  Pedro A de Alarcon; Katherine K Matthay; Wendy B London; Arlene Naranjo; Sheena C Tenney; Jessica A Panzer; Michael D Hogarty; Julie R Park; John M Maris; Susan L Cohn
Journal:  Lancet Child Adolesc Health       Date:  2017-11-03

10.  Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.

Authors:  Georgina Berridge; David A Menassa; Teresa Moloney; Patrick J Waters; Imogen Welding; Selina Thomsen; Sameer Zuberi; Roman Fischer; A Radu Aricescu; Michael Pike; Russell C Dale; Benedikt Kessler; Angela Vincent; Ming Lim; Sarosh R Irani; Bethan Lang
Journal:  Neurology       Date:  2018-07-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.